Posts Categorized: MS News

Motability offers manual wheelchair lease to customers

Source Independent Living:  An interesting new supplementary service has just been launched by Motability. An interesting new supplementary service has just been launched by Motability. People who lease an adapted vehicle, including WAVs (wheelchair accessible vehicles) through the scheme can now lease a lightweight manual wheelchair at the same time. The wheelchair option is available… Read more »

Mitochondria and progressive MS

Source MS Society: Small but mighty, mitochondria provide the energy that busy nerve cells need to survive. We spoke with mitochondria expert Dr Don Mahad, from the University of Edinburgh, about what makes them so special – and what goes wrong in MS. Mitochondria and progressive MS ‘I’m interested in energy production and demand in the… Read more »

Gabapentin and pregabalin – new rules for prescriptions

Source MS Trust:  From 1 April 2019, gabapentin and pregabalin have been reclassified as controlled drugs, leading to changes in how they are prescribed.   Gabapentin and pregabalin are drugs used to treat a range of symptoms caused by MS, such as nerve pain, spasticity and spasms. Following concerns about misuse of these drugs, on 1 April the law changed so… Read more »

Access improvements at 73 railway stations

Source BBC: Lifts and adjustable ticket counters will be among the new measures brought in over the next five years. The changes, part of an “inclusive transport strategy”, will help disabled passengers as well as those travelling with children or luggage.  Liverpool Central and Luton in England, Barry Town in Wales, and Dumfries in Scotland are among… Read more »

Anyone taking Plegridy?

Source MS Trust: NICE will be assessing Plegridy to decide whether it should continue to be prescribed by the NHS in England. We’ll be telling NICE why we think it should be an option. If you are taking Plegridy we’d really like to know what you think of it, your experiences good and bad.  If you… Read more »

New £1.8m research to explore cognitive screening and rehabilitation in multiple sclerosis

Source University of Nottingham: A new £1.85 million research study led by Professor Roshan das Nair at the Institute of Mental Health aims to develop a new computerised screening tool to detect the “invisible” cognitive impairments that can appear early in the life of a person living with multiple sclerosis (MS). Approximately 100 people are diagnosed… Read more »

How do families affected by MS manage health information

Source MS Trust: Couples and families develop their own unique ways of dealing with an MS diagnosis. A recent UK study looked at how different family units affected by MS, cope with receiving MS health information.  In this study, UK researchers wanted to understand how couples and families affected by MS cope with health information. The… Read more »

The relief of diagnosis

Source Multiple Sclerosis Net: Being diagnosed with an incurable, chronic illness such as Multiple Sclerosis is never a pleasant experience. However, for many people, getting that final confirmation creates an extreme sense of relief. That sounds pretty peculiar to many people, as getting a diagnosis of Multiple Sclerosis is not an easy process. With no single test to determine… Read more »

The MS kids are alright

Source MS Trust: How your children will cope with your MS, is an ongoing concern for the majority of parents following diagnosis. Here Martin Baum, who was diagnosed with MS over 20 years ago and his son Josh, discuss how they coped and the impact it has had on them over the years. Many years ago,… Read more »

Innovative clinical research using robotic technology to improve balance & mobility for people living with MS

A ground-breaking clinical research trial is inviting people living with Multiple Sclerosis (MS) to take part in the evaluation of a balance exercise program using a robotic walking device. This trial is the only research trial in this field taking place in the UK for people diagnosed and living with MS. The trial is pioneering… Read more »